AKT1 and neoplasm: For secondary tumor, addition of Akt inhibitor to RT + αPD-L1/αCTLA-4 resulted in greater tumor growth inhibition than RT + αPD-L1/αCTLA-4, although the difference was not statistically significant (Figure 4B).